nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—ALB—type 1 diabetes mellitus	0.667	1	CbGaD
Naproxen—Pulmonary eosinophilia—Ramipril—type 1 diabetes mellitus	0.0171	0.072	CcSEcCtD
Naproxen—Stomach ache—Ramipril—type 1 diabetes mellitus	0.00734	0.0309	CcSEcCtD
Naproxen—Kidney function abnormal—Ramipril—type 1 diabetes mellitus	0.00646	0.0272	CcSEcCtD
Naproxen—Neuralgia—Ramipril—type 1 diabetes mellitus	0.00449	0.0189	CcSEcCtD
Naproxen—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.0036	0.0152	CcSEcCtD
Naproxen—Proteinuria—Ramipril—type 1 diabetes mellitus	0.00355	0.015	CcSEcCtD
Naproxen—Protein urine present—Ramipril—type 1 diabetes mellitus	0.0035	0.0148	CcSEcCtD
Naproxen—Cough increased—Ramipril—type 1 diabetes mellitus	0.00341	0.0144	CcSEcCtD
Naproxen—Glossitis—Ramipril—type 1 diabetes mellitus	0.00339	0.0143	CcSEcCtD
Naproxen—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00328	0.0138	CcSEcCtD
Naproxen—Vasculitis—Ramipril—type 1 diabetes mellitus	0.0032	0.0135	CcSEcCtD
Naproxen—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00295	0.0124	CcSEcCtD
Naproxen—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00282	0.0119	CcSEcCtD
Naproxen—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.00279	0.0118	CcSEcCtD
Naproxen—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00258	0.0109	CcSEcCtD
Naproxen—Polyuria—Ramipril—type 1 diabetes mellitus	0.00258	0.0109	CcSEcCtD
Naproxen—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00256	0.0108	CcSEcCtD
Naproxen—Deafness—Ramipril—type 1 diabetes mellitus	0.00253	0.0107	CcSEcCtD
Naproxen—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00253	0.0107	CcSEcCtD
Naproxen—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00252	0.0106	CcSEcCtD
Naproxen—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.00251	0.0106	CcSEcCtD
Naproxen—Amnesia—Ramipril—type 1 diabetes mellitus	0.00241	0.0102	CcSEcCtD
Naproxen—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.0024	0.0101	CcSEcCtD
Naproxen—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00238	0.01	CcSEcCtD
Naproxen—Purpura—Ramipril—type 1 diabetes mellitus	0.00235	0.00991	CcSEcCtD
Naproxen—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00234	0.00986	CcSEcCtD
Naproxen—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00232	0.00978	CcSEcCtD
Naproxen—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00232	0.00978	CcSEcCtD
Naproxen—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00212	0.00894	CcSEcCtD
Naproxen—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00209	0.00881	CcSEcCtD
Naproxen—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00207	0.00872	CcSEcCtD
Naproxen—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00205	0.00863	CcSEcCtD
Naproxen—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00204	0.0086	CcSEcCtD
Naproxen—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00204	0.0086	CcSEcCtD
Naproxen—Gastritis—Ramipril—type 1 diabetes mellitus	0.00201	0.00845	CcSEcCtD
Naproxen—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00196	0.00825	CcSEcCtD
Naproxen—Asthma—Ramipril—type 1 diabetes mellitus	0.00196	0.00825	CcSEcCtD
Naproxen—Influenza—Ramipril—type 1 diabetes mellitus	0.00196	0.00825	CcSEcCtD
Naproxen—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00194	0.00817	CcSEcCtD
Naproxen—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00192	0.00809	CcSEcCtD
Naproxen—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00191	0.00804	CcSEcCtD
Naproxen—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00188	0.00794	CcSEcCtD
Naproxen—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00188	0.00791	CcSEcCtD
Naproxen—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00186	0.00784	CcSEcCtD
Naproxen—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00179	0.00753	CcSEcCtD
Naproxen—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00173	0.00729	CcSEcCtD
Naproxen—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00172	0.00725	CcSEcCtD
Naproxen—Renal failure—Ramipril—type 1 diabetes mellitus	0.00172	0.00723	CcSEcCtD
Naproxen—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00171	0.00721	CcSEcCtD
Naproxen—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00171	0.00721	CcSEcCtD
Naproxen—Stomatitis—Ramipril—type 1 diabetes mellitus	0.0017	0.00717	CcSEcCtD
Naproxen—Jaundice—Ramipril—type 1 diabetes mellitus	0.0017	0.00717	CcSEcCtD
Naproxen—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.0017	0.00715	CcSEcCtD
Naproxen—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.0017	0.00715	CcSEcCtD
Naproxen—Sweating—Ramipril—type 1 diabetes mellitus	0.00167	0.00705	CcSEcCtD
Naproxen—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00165	0.00696	CcSEcCtD
Naproxen—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00165	0.00694	CcSEcCtD
Naproxen—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00164	0.0069	CcSEcCtD
Naproxen—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00163	0.00687	CcSEcCtD
Naproxen—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00157	0.0066	CcSEcCtD
Naproxen—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00154	0.00651	CcSEcCtD
Naproxen—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00154	0.00649	CcSEcCtD
Naproxen—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00151	0.00637	CcSEcCtD
Naproxen—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00148	0.00625	CcSEcCtD
Naproxen—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00146	0.00616	CcSEcCtD
Naproxen—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00142	0.00597	CcSEcCtD
Naproxen—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00141	0.00595	CcSEcCtD
Naproxen—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.0014	0.0059	CcSEcCtD
Naproxen—Alopecia—Ramipril—type 1 diabetes mellitus	0.00139	0.00584	CcSEcCtD
Naproxen—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00137	0.00579	CcSEcCtD
Naproxen—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00136	0.00575	CcSEcCtD
Naproxen—Erythema—Ramipril—type 1 diabetes mellitus	0.00136	0.00575	CcSEcCtD
Naproxen—Tension—Ramipril—type 1 diabetes mellitus	0.00134	0.00564	CcSEcCtD
Naproxen—Nervousness—Ramipril—type 1 diabetes mellitus	0.00133	0.00558	CcSEcCtD
Naproxen—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00131	0.00553	CcSEcCtD
Naproxen—Tremor—Ramipril—type 1 diabetes mellitus	0.00128	0.00539	CcSEcCtD
Naproxen—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00127	0.00533	CcSEcCtD
Naproxen—Angioedema—Ramipril—type 1 diabetes mellitus	0.00125	0.00525	CcSEcCtD
Naproxen—Malaise—Ramipril—type 1 diabetes mellitus	0.00123	0.00519	CcSEcCtD
Naproxen—Vertigo—Ramipril—type 1 diabetes mellitus	0.00123	0.00517	CcSEcCtD
Naproxen—Syncope—Ramipril—type 1 diabetes mellitus	0.00122	0.00516	CcSEcCtD
Naproxen—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00122	0.00515	CcSEcCtD
Naproxen—Palpitations—Ramipril—type 1 diabetes mellitus	0.00121	0.00508	CcSEcCtD
Naproxen—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.0012	0.00505	CcSEcCtD
Naproxen—Cough—Ramipril—type 1 diabetes mellitus	0.00119	0.00502	CcSEcCtD
Naproxen—Convulsion—Ramipril—type 1 diabetes mellitus	0.00118	0.00498	CcSEcCtD
Naproxen—Chest pain—Ramipril—type 1 diabetes mellitus	0.00116	0.0049	CcSEcCtD
Naproxen—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00116	0.0049	CcSEcCtD
Naproxen—Myalgia—Ramipril—type 1 diabetes mellitus	0.00116	0.0049	CcSEcCtD
Naproxen—Anxiety—Ramipril—type 1 diabetes mellitus	0.00116	0.00488	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00115	0.00486	CcSEcCtD
Naproxen—Discomfort—Ramipril—type 1 diabetes mellitus	0.00115	0.00484	CcSEcCtD
Naproxen—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00114	0.00479	CcSEcCtD
Naproxen—Confusional state—Ramipril—type 1 diabetes mellitus	0.00112	0.00473	CcSEcCtD
Naproxen—Oedema—Ramipril—type 1 diabetes mellitus	0.00111	0.00469	CcSEcCtD
Naproxen—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00111	0.00469	CcSEcCtD
Naproxen—Shock—Ramipril—type 1 diabetes mellitus	0.0011	0.00462	CcSEcCtD
Naproxen—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00109	0.0046	CcSEcCtD
Naproxen—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00109	0.00459	CcSEcCtD
Naproxen—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00109	0.00458	CcSEcCtD
Naproxen—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00108	0.00456	CcSEcCtD
Naproxen—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00108	0.00454	CcSEcCtD
Naproxen—Anorexia—Ramipril—type 1 diabetes mellitus	0.00106	0.00447	CcSEcCtD
Naproxen—Hypotension—Ramipril—type 1 diabetes mellitus	0.00104	0.00438	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00101	0.00428	CcSEcCtD
Naproxen—Insomnia—Ramipril—type 1 diabetes mellitus	0.00101	0.00424	CcSEcCtD
Naproxen—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.001	0.00421	CcSEcCtD
Naproxen—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000993	0.00418	CcSEcCtD
Naproxen—Somnolence—Ramipril—type 1 diabetes mellitus	0.00099	0.00417	CcSEcCtD
Naproxen—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00098	0.00413	CcSEcCtD
Naproxen—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000968	0.00408	CcSEcCtD
Naproxen—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000961	0.00405	CcSEcCtD
Naproxen—Fatigue—Ramipril—type 1 diabetes mellitus	0.00096	0.00405	CcSEcCtD
Naproxen—Constipation—Ramipril—type 1 diabetes mellitus	0.000952	0.00401	CcSEcCtD
Naproxen—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000918	0.00387	CcSEcCtD
Naproxen—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000911	0.00384	CcSEcCtD
Naproxen—Urticaria—Ramipril—type 1 diabetes mellitus	0.000885	0.00373	CcSEcCtD
Naproxen—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00088	0.00371	CcSEcCtD
Naproxen—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00088	0.00371	CcSEcCtD
Naproxen—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00082	0.00346	CcSEcCtD
Naproxen—Asthenia—Ramipril—type 1 diabetes mellitus	0.000799	0.00337	CcSEcCtD
Naproxen—Pruritus—Ramipril—type 1 diabetes mellitus	0.000788	0.00332	CcSEcCtD
Naproxen—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000762	0.00321	CcSEcCtD
Naproxen—Dizziness—Ramipril—type 1 diabetes mellitus	0.000736	0.0031	CcSEcCtD
Naproxen—Vomiting—Ramipril—type 1 diabetes mellitus	0.000708	0.00298	CcSEcCtD
Naproxen—Rash—Ramipril—type 1 diabetes mellitus	0.000702	0.00296	CcSEcCtD
Naproxen—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000702	0.00296	CcSEcCtD
Naproxen—Headache—Ramipril—type 1 diabetes mellitus	0.000698	0.00294	CcSEcCtD
Naproxen—Nausea—Ramipril—type 1 diabetes mellitus	0.000661	0.00279	CcSEcCtD
Naproxen—Fenoprofen—ALB—type 1 diabetes mellitus	0.000562	0.281	CrCbGaD
Naproxen—Indomethacin—ALB—type 1 diabetes mellitus	0.000415	0.207	CrCbGaD
Naproxen—Flurbiprofen—ALB—type 1 diabetes mellitus	0.000367	0.183	CrCbGaD
Naproxen—Ketoprofen—ALB—type 1 diabetes mellitus	0.000332	0.166	CrCbGaD
Naproxen—Ibuprofen—ALB—type 1 diabetes mellitus	0.000326	0.163	CrCbGaD
Naproxen—PTGS1—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	0.000108	0.00116	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—TNF—type 1 diabetes mellitus	0.000107	0.00115	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IFNG—type 1 diabetes mellitus	0.000107	0.00115	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—PRKCQ—type 1 diabetes mellitus	0.000105	0.00113	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—HBA1—type 1 diabetes mellitus	0.000105	0.00112	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IFNG—type 1 diabetes mellitus	0.000105	0.00112	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—APOC3—type 1 diabetes mellitus	0.000104	0.00112	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000104	0.00111	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000103	0.0011	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GSTT1—type 1 diabetes mellitus	0.000103	0.0011	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—VAV1—type 1 diabetes mellitus	0.000102	0.00109	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000102	0.00109	CbGpPWpGaD
Naproxen—SLCO1A2—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.000101	0.00108	CbGpPWpGaD
Naproxen—AKR1C3—Disease—NOS1—type 1 diabetes mellitus	0.0001	0.00107	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	9.98e-05	0.00107	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SELL—type 1 diabetes mellitus	9.81e-05	0.00105	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	9.57e-05	0.00102	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IL1B—type 1 diabetes mellitus	9.57e-05	0.00102	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ABCC8—type 1 diabetes mellitus	9.57e-05	0.00102	CbGpPWpGaD
Naproxen—SLC22A6—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	9.51e-05	0.00102	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	9.45e-05	0.00101	CbGpPWpGaD
Naproxen—AKR1C3—Disease—PRKCQ—type 1 diabetes mellitus	9.39e-05	0.001	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL1B—type 1 diabetes mellitus	9.36e-05	0.001	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—CASP3—type 1 diabetes mellitus	9.34e-05	0.000999	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—ITPR3—type 1 diabetes mellitus	9.33e-05	0.000999	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL2—type 1 diabetes mellitus	9.32e-05	0.000997	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—IGF2—type 1 diabetes mellitus	9.25e-05	0.00099	CbGpPWpGaD
Naproxen—AKR1C3—Disease—VAV1—type 1 diabetes mellitus	9.12e-05	0.000976	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ABCC8—type 1 diabetes mellitus	8.93e-05	0.000956	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—HBA2—type 1 diabetes mellitus	8.93e-05	0.000956	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—SH2B3—type 1 diabetes mellitus	8.78e-05	0.00094	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—TNF—type 1 diabetes mellitus	8.74e-05	0.000935	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—APOC3—type 1 diabetes mellitus	8.73e-05	0.000934	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IAPP—type 1 diabetes mellitus	8.73e-05	0.000934	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	8.73e-05	0.000934	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—KCNJ11—type 1 diabetes mellitus	8.69e-05	0.00093	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—IL6—type 1 diabetes mellitus	8.67e-05	0.000928	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	8.58e-05	0.000919	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	8.57e-05	0.000917	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	8.57e-05	0.000917	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—G6PC2—type 1 diabetes mellitus	8.4e-05	0.000899	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	8.25e-05	0.000883	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GCG—type 1 diabetes mellitus	8.17e-05	0.000874	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	8.16e-05	0.000873	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	8.16e-05	0.000873	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	8.1e-05	0.000867	CbGpPWpGaD
Naproxen—PTGS2—Disease—G6PC2—type 1 diabetes mellitus	7.96e-05	0.000852	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CD86—type 1 diabetes mellitus	7.95e-05	0.000851	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—IL2RA—type 1 diabetes mellitus	7.79e-05	0.000833	CbGpPWpGaD
Naproxen—ALB—Hemostasis—ITPR3—type 1 diabetes mellitus	7.7e-05	0.000823	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—SST—type 1 diabetes mellitus	7.66e-05	0.00082	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	7.64e-05	0.000818	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—ADRB1—type 1 diabetes mellitus	7.63e-05	0.000816	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	7.57e-05	0.00081	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ITPR3—type 1 diabetes mellitus	7.33e-05	0.000785	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ABCC8—type 1 diabetes mellitus	7.28e-05	0.000779	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SH2B3—type 1 diabetes mellitus	7.24e-05	0.000775	CbGpPWpGaD
Naproxen—AKR1C3—Disease—ERBB3—type 1 diabetes mellitus	7.17e-05	0.000767	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—EGFR—type 1 diabetes mellitus	7.13e-05	0.000763	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—HBA2—type 1 diabetes mellitus	7.09e-05	0.000759	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—KCNJ11—type 1 diabetes mellitus	7.06e-05	0.000755	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL6—type 1 diabetes mellitus	7.06e-05	0.000755	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CCR5—type 1 diabetes mellitus	7.05e-05	0.000755	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	7.03e-05	0.000753	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	6.98e-05	0.000746	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	6.95e-05	0.000743	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	6.93e-05	0.000741	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—CAT—type 1 diabetes mellitus	6.92e-05	0.00074	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—HBA1—type 1 diabetes mellitus	6.9e-05	0.000739	CbGpPWpGaD
Naproxen—AKR1C3—Disease—HLA-A—type 1 diabetes mellitus	6.87e-05	0.000735	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—APOC3—type 1 diabetes mellitus	6.86e-05	0.000734	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—GCG—type 1 diabetes mellitus	6.83e-05	0.000731	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TNF—type 1 diabetes mellitus	6.79e-05	0.000726	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GSTT1—type 1 diabetes mellitus	6.74e-05	0.000721	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—G6PC2—type 1 diabetes mellitus	6.67e-05	0.000713	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	6.59e-05	0.000705	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	6.58e-05	0.000704	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	6.55e-05	0.000701	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ITPR3—type 1 diabetes mellitus	6.39e-05	0.000683	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—VAV1—type 1 diabetes mellitus	6.39e-05	0.000683	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	6.37e-05	0.000681	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	6.35e-05	0.000679	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—HBA1—type 1 diabetes mellitus	6.01e-05	0.000643	CbGpPWpGaD
Naproxen—AKR1C3—Disease—NOS2—type 1 diabetes mellitus	5.98e-05	0.00064	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—APOC3—type 1 diabetes mellitus	5.97e-05	0.000639	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ITPR3—type 1 diabetes mellitus	5.96e-05	0.000638	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	5.94e-05	0.000635	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GSTT1—type 1 diabetes mellitus	5.87e-05	0.000628	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CD80—type 1 diabetes mellitus	5.8e-05	0.000621	CbGpPWpGaD
Naproxen—ALB—Hemostasis—NOS1—type 1 diabetes mellitus	5.79e-05	0.00062	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IGF2—type 1 diabetes mellitus	5.78e-05	0.000619	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ABCC8—type 1 diabetes mellitus	5.78e-05	0.000618	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—HBA2—type 1 diabetes mellitus	5.77e-05	0.000617	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—KCNJ11—type 1 diabetes mellitus	5.76e-05	0.000616	CbGpPWpGaD
Naproxen—ALB—Metabolism—HBA2—type 1 diabetes mellitus	5.74e-05	0.000614	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—HBA1—type 1 diabetes mellitus	5.61e-05	0.0006	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	5.61e-05	0.0006	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—APOC3—type 1 diabetes mellitus	5.57e-05	0.000596	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CD86—type 1 diabetes mellitus	5.57e-05	0.000596	CbGpPWpGaD
Naproxen—AKR1C3—Disease—INS—type 1 diabetes mellitus	5.48e-05	0.000586	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL6—type 1 diabetes mellitus	5.48e-05	0.000586	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GSTT1—type 1 diabetes mellitus	5.47e-05	0.000586	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—G6PC2—type 1 diabetes mellitus	5.42e-05	0.00058	CbGpPWpGaD
Naproxen—ALB—Hemostasis—PRKCQ—type 1 diabetes mellitus	5.42e-05	0.00058	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.41e-05	0.000579	CbGpPWpGaD
Naproxen—ALB—Metabolism—G6PC2—type 1 diabetes mellitus	5.39e-05	0.000577	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GCG—type 1 diabetes mellitus	5.37e-05	0.000574	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	5.36e-05	0.000574	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.28e-05	0.000565	CbGpPWpGaD
Naproxen—ALB—Hemostasis—VAV1—type 1 diabetes mellitus	5.27e-05	0.000563	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.14e-05	0.00055	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.02e-05	0.000537	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.94e-05	0.000528	CbGpPWpGaD
Naproxen—AKR1C3—Disease—TYK2—type 1 diabetes mellitus	4.9e-05	0.000524	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.87e-05	0.000521	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ITPR3—type 1 diabetes mellitus	4.86e-05	0.00052	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	4.85e-05	0.000519	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	4.83e-05	0.000517	CbGpPWpGaD
Naproxen—PTGS2—Disease—SLC11A1—type 1 diabetes mellitus	4.82e-05	0.000516	CbGpPWpGaD
Naproxen—AKR1C3—Disease—NOS3—type 1 diabetes mellitus	4.81e-05	0.000514	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IGF2—type 1 diabetes mellitus	4.77e-05	0.00051	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ABCC8—type 1 diabetes mellitus	4.7e-05	0.000503	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	4.7e-05	0.000502	CbGpPWpGaD
Naproxen—ALB—Metabolism—ABCC8—type 1 diabetes mellitus	4.68e-05	0.0005	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GCG—type 1 diabetes mellitus	4.67e-05	0.0005	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	4.62e-05	0.000494	CbGpPWpGaD
Naproxen—PTGS2—Disease—ITPR3—type 1 diabetes mellitus	4.61e-05	0.000493	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—INS—type 1 diabetes mellitus	4.59e-05	0.000491	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	4.58e-05	0.00049	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—HBA1—type 1 diabetes mellitus	4.57e-05	0.000489	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—KCNJ11—type 1 diabetes mellitus	4.57e-05	0.000489	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	4.56e-05	0.000488	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—APOC3—type 1 diabetes mellitus	4.54e-05	0.000486	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CAT—type 1 diabetes mellitus	4.54e-05	0.000486	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GSTT1—type 1 diabetes mellitus	4.46e-05	0.000478	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CD4—type 1 diabetes mellitus	4.43e-05	0.000474	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	4.41e-05	0.000472	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GCG—type 1 diabetes mellitus	4.36e-05	0.000467	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOC3—type 1 diabetes mellitus	4.31e-05	0.000461	CbGpPWpGaD
Naproxen—PTGS2—Disease—IAPP—type 1 diabetes mellitus	4.31e-05	0.000461	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ALB—type 1 diabetes mellitus	4.21e-05	0.00045	CbGpPWpGaD
Naproxen—PTGS2—Disease—B2M—type 1 diabetes mellitus	4.13e-05	0.000442	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	4.11e-05	0.00044	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CD80—type 1 diabetes mellitus	4.06e-05	0.000435	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—NOS3—type 1 diabetes mellitus	4.03e-05	0.000431	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IL2RA—type 1 diabetes mellitus	4.01e-05	0.000429	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	4.01e-05	0.000429	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CAT—type 1 diabetes mellitus	3.96e-05	0.000423	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ITPR3—type 1 diabetes mellitus	3.86e-05	0.000413	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—INS—type 1 diabetes mellitus	3.84e-05	0.000411	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	3.83e-05	0.00041	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	3.77e-05	0.000404	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—KCNJ11—type 1 diabetes mellitus	3.72e-05	0.000398	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.71e-05	0.000397	CbGpPWpGaD
Naproxen—ALB—Metabolism—KCNJ11—type 1 diabetes mellitus	3.7e-05	0.000396	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CAT—type 1 diabetes mellitus	3.69e-05	0.000395	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—HBA1—type 1 diabetes mellitus	3.63e-05	0.000388	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOC3—type 1 diabetes mellitus	3.61e-05	0.000386	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GCG—type 1 diabetes mellitus	3.56e-05	0.00038	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GSTT1—type 1 diabetes mellitus	3.54e-05	0.000379	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS1—type 1 diabetes mellitus	3.47e-05	0.000371	CbGpPWpGaD
Naproxen—ALB—Hemostasis—NOS2—type 1 diabetes mellitus	3.45e-05	0.000369	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.43e-05	0.000367	CbGpPWpGaD
Naproxen—AKR1C3—Disease—STAT3—type 1 diabetes mellitus	3.43e-05	0.000367	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.37e-05	0.00036	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	3.27e-05	0.00035	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	3.27e-05	0.000349	CbGpPWpGaD
Naproxen—PTGS2—Disease—PRKCQ—type 1 diabetes mellitus	3.24e-05	0.000347	CbGpPWpGaD
Naproxen—PTGS2—Disease—VAV1—type 1 diabetes mellitus	3.15e-05	0.000337	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ITPR3—type 1 diabetes mellitus	3.14e-05	0.000336	CbGpPWpGaD
Naproxen—ALB—Metabolism—ITPR3—type 1 diabetes mellitus	3.12e-05	0.000334	CbGpPWpGaD
Naproxen—AKR1C3—Disease—EGFR—type 1 diabetes mellitus	3.12e-05	0.000333	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IGF1—type 1 diabetes mellitus	3.06e-05	0.000328	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	3.03e-05	0.000324	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—INS—type 1 diabetes mellitus	3.02e-05	0.000323	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CAT—type 1 diabetes mellitus	3.01e-05	0.000322	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—HBA1—type 1 diabetes mellitus	2.95e-05	0.000316	CbGpPWpGaD
Naproxen—ALB—Metabolism—HBA1—type 1 diabetes mellitus	2.94e-05	0.000314	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOC3—type 1 diabetes mellitus	2.94e-05	0.000314	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOC3—type 1 diabetes mellitus	2.92e-05	0.000312	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTT1—type 1 diabetes mellitus	2.88e-05	0.000308	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTT1—type 1 diabetes mellitus	2.87e-05	0.000307	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.86e-05	0.000306	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL2—type 1 diabetes mellitus	2.85e-05	0.000305	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GCG—type 1 diabetes mellitus	2.82e-05	0.000302	CbGpPWpGaD
Naproxen—ALB—Hemostasis—NOS3—type 1 diabetes mellitus	2.78e-05	0.000297	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ALB—type 1 diabetes mellitus	2.77e-05	0.000296	CbGpPWpGaD
Naproxen—PTGS2—Disease—CD86—type 1 diabetes mellitus	2.75e-05	0.000294	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	2.66e-05	0.000284	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—NOS3—type 1 diabetes mellitus	2.65e-05	0.000283	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—INS—type 1 diabetes mellitus	2.63e-05	0.000281	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	2.59e-05	0.000277	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	2.55e-05	0.000273	CbGpPWpGaD
Naproxen—PTGS2—Disease—ERBB3—type 1 diabetes mellitus	2.48e-05	0.000265	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—INS—type 1 diabetes mellitus	2.45e-05	0.000262	CbGpPWpGaD
Naproxen—PTGS2—Disease—CCR5—type 1 diabetes mellitus	2.44e-05	0.000261	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ALB—type 1 diabetes mellitus	2.41e-05	0.000258	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	2.4e-05	0.000257	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.4e-05	0.000257	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6—type 1 diabetes mellitus	2.4e-05	0.000256	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CAT—type 1 diabetes mellitus	2.39e-05	0.000256	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	2.39e-05	0.000256	CbGpPWpGaD
Naproxen—PTGS2—Disease—HLA-A—type 1 diabetes mellitus	2.37e-05	0.000254	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IL2—type 1 diabetes mellitus	2.35e-05	0.000252	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	2.35e-05	0.000251	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—NOS3—type 1 diabetes mellitus	2.3e-05	0.000246	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	2.3e-05	0.000246	CbGpPWpGaD
Naproxen—ALB—Metabolism—GCG—type 1 diabetes mellitus	2.28e-05	0.000244	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ALB—type 1 diabetes mellitus	2.25e-05	0.00024	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	2.18e-05	0.000234	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.18e-05	0.000234	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	2.16e-05	0.000231	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—NOS3—type 1 diabetes mellitus	2.15e-05	0.00023	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS2—type 1 diabetes mellitus	2.07e-05	0.000221	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	2.05e-05	0.00022	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	2.04e-05	0.000218	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	2e-05	0.000215	CbGpPWpGaD
Naproxen—PTGS2—Disease—CD80—type 1 diabetes mellitus	2e-05	0.000214	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—INS—type 1 diabetes mellitus	2e-05	0.000214	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	1.94e-05	0.000208	CbGpPWpGaD
Naproxen—ALB—Metabolism—CAT—type 1 diabetes mellitus	1.93e-05	0.000207	CbGpPWpGaD
Naproxen—PTGS2—Disease—INS—type 1 diabetes mellitus	1.89e-05	0.000203	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	1.87e-05	0.0002	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.85e-05	0.000198	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ALB—type 1 diabetes mellitus	1.83e-05	0.000196	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NOS3—type 1 diabetes mellitus	1.75e-05	0.000187	CbGpPWpGaD
Naproxen—PTGS2—Disease—TYK2—type 1 diabetes mellitus	1.69e-05	0.000181	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—type 1 diabetes mellitus	1.68e-05	0.000179	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS3—type 1 diabetes mellitus	1.66e-05	0.000178	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	1.6e-05	0.000171	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—INS—type 1 diabetes mellitus	1.59e-05	0.00017	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	1.58e-05	0.000169	CbGpPWpGaD
Naproxen—PTGS2—Disease—CD4—type 1 diabetes mellitus	1.53e-05	0.000164	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ALB—type 1 diabetes mellitus	1.45e-05	0.000156	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NOS3—type 1 diabetes mellitus	1.39e-05	0.000149	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	1.35e-05	0.000145	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	1.29e-05	0.000138	CbGpPWpGaD
Naproxen—ALB—Metabolism—INS—type 1 diabetes mellitus	1.28e-05	0.000137	CbGpPWpGaD
Naproxen—PTGS2—Disease—STAT3—type 1 diabetes mellitus	1.18e-05	0.000127	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	1.18e-05	0.000127	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	1.13e-05	0.000121	CbGpPWpGaD
Naproxen—ALB—Metabolism—NOS3—type 1 diabetes mellitus	1.13e-05	0.00012	CbGpPWpGaD
Naproxen—PTGS2—Disease—EGFR—type 1 diabetes mellitus	1.08e-05	0.000115	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	1.05e-05	0.000112	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	9.63e-06	0.000103	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	9.21e-06	9.86e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	8.98e-06	9.6e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—type 1 diabetes mellitus	8.28e-06	8.86e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	8.23e-06	8.8e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	7.87e-06	8.42e-05	CbGpPWpGaD
